Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T ICU 2019 | EuroCARTForce: a platform for progress

Michael von Bergwelt • 10 Jul 2019
CAR-T ICU 2019
CAR-T

In this video, Michael von Bergwelt, MD, LMU Hospital Munich, Munich, Germany, discusses the objectives of the formation of EuroCARTForce and the challenges of utilizing CAR T cells and immunotherapy. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

More from Michael von Bergwelt

Increase in cancer patient transfers to the ICU: what does it come down to?
2:25
Increase in cancer patient transfers to the ICU: what does it come down to?
Michael von Bergwelt • 10 Jul 2019
Preparing the critical care workforce for CAR-T
1:14
Preparing the critical care workforce for CAR-T
Michael von Bergwelt • 10 Jul 2019
Intensive care for CAR-T: bridge to treatment and response
2:30
Intensive care for CAR-T: bridge to treatment and response
Michael von Bergwelt • 15 Mar 2019
Learnings from a CAR-T center: leukapheresis, bridging therapy, toxicities & more
3:43
Learnings from a CAR-T center: leukapheresis, bridging therapy, toxicities & more
Michael von Bergwelt • 15 Mar 2019
The content of VJHemOnc is intended for healthcare professionals